Insuman Comb 25 Solostar (Insulin Human)

Insuman Comb 25 Solostar provides insulin therapy for the diabetes mellitus disease family.

• Diabetes mellitus: helps achieve target blood glucose control.
• Type 1 diabetes: supplies basal and prandial insulin to replace deficient endogenous insulin.
• Type 2 diabetes: used when oral antidiabetic agents are insufficient to maintain glycaemic goals.

• Insulin Human binds to insulin receptors on cell membranes, activating the receptor’s intrinsic tyrosine kinase activity. This triggers downstream signaling pathways that promote translocation of glucose transporter‑4 (GLUT‑4) to the cell surface, enhancing glucose uptake in muscle and adipose tissue, while suppressing hepatic gluconeogenesis and glycogenolysis, thereby lowering circulating blood glucose.

Insuman Comb 25 Solostar may cause a range of adverse reactions.

Common Side Effects

• Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, and confusion.
• Injection‑site reactions: redness, swelling, or itching at the injection site.
• Weight gain: modest increase in body weight with chronic use.
• Lipodystrophy: localized changes in fat tissue at injection sites.
• Edema: mild peripheral swelling, especially in the lower limbs.
• Headache: occasional mild to moderate headache.

Serious or Rare Side Effects

• Severe hypoglycaemia: profound low blood glucose requiring assistance.
• Allergic reactions: urticaria, angio‑edema, or anaphylaxis.
• Insulin antibodies: formation of antibodies that may alter insulin action.
• Serum sickness‑like reactions: fever, rash, arthralgia in rare cases.

When using Insuman Comb 25 Solostar, several safety considerations apply.

• Dose individualisation: adjust dose based on frequent blood glucose monitoring.
• Hypoglycaemia risk: avoid administration if patient is already experiencing low glucose.
• Illness management: increase monitoring and possibly adjust dose during acute illness.
• Renal/hepatic impairment: use with caution and consider dose reduction.
• Concomitant medications: be aware of drugs that may mask hypoglycaemia symptoms.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 25 Solostar can interact with other medicines, affecting glucose control.

Major Interactions (Avoid)

• Sulfonylureas or meglitinides: combined use may cause severe hypoglycaemia.
• High‑dose alcohol: can potentiate insulin’s glucose‑lowering effect.
• Beta‑blockers: may mask typical hypoglycaemia warning signs.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may enhance insulin sensitivity, requiring dose review.
• Corticosteroids: can increase blood glucose, necessitating higher insulin doses.
• Thiazide diuretics: may raise glucose levels, requiring closer monitoring.
• Thyroid hormones: can alter insulin requirements.
• Beta‑blockers (monitor): may blunt autonomic responses to low glucose.